Beth Isreal Medical Center — New York, New York

Beth Isreal Medical Center is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Isreal Medical Center has participated in 4 clinical trials.

Therapeutic areas: Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Respiratory Failure, Dupuytren's Contracture.

Sponsors: Celldex Therapeutics, Beth Israel Medical Center, Endo Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Isreal Medical Center?

Beth Isreal Medical Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Isreal Medical Center conducted?

Beth Isreal Medical Center has 4 clinical trials on record. Their work covers Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Respiratory Failure, Dupuytren's Contracture.

Is Beth Isreal Medical Center accredited by Crixeo Health?

Beth Isreal Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Isreal Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.